American Surgical Association

Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors

Retrieved on: 
星期一, 二月 12, 2024
Hospital, American Heart Association, Artificial intelligence, Society, University, American College, Health, American Surgical Association, Cardiothoracic surgery, Bangladesh Technical Education Board, Register, NIH, Duke University Hospital, JAMA, Physician, MDAI, International Society, General surgery, Abstract, Internal medicine, United, Society of Thoracic Surgeons, Research, Human services, Spectral, FDA, American College of Surgeons, National Science Foundation, American Burn Association, Lung transplantation, Publication, Medical device

DALLAS, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on the unmet need for improved medical diagnostics to allow faster and more accurate treatment decisions in wound care, today announces the appointment of Dr. J. Michael DiMaio to its Board of Directors, effective February 7, 2024.

Key Points: 
  • DALLAS, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on the unmet need for improved medical diagnostics to allow faster and more accurate treatment decisions in wound care, today announces the appointment of Dr. J. Michael DiMaio to its Board of Directors, effective February 7, 2024.
  • Dr. DiMaio joins the Board as a non-executive member to fill the vacancy left by the departure of Mr. Michael Murphy.
  • Dr. Michael DiMaio is one of the Company’s founders and previously served as the Company’s Chief Executive Officer and Chairman of the Board of Directors from 2011 to 2020.
  • "I am pleased to welcome back Dr. Michael DiMaio to Spectral AI’s Board of Directors," said Richard Cotton, Chairman of the Board of Directors.

aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor

Retrieved on: 
星期四, 一月 18, 2024
Mortality, ILD, Patient, Outline of health sciences, Wayne A. I. Frederick, Sarcoidosis, Research, Biology, Fibrosis, Associate, Scar, ACS, Dean (education), Howard University, SAN, Knowledge, University, National academy, Humana, Scleroderma, Business, Small RNA, American Surgical Association, Human, Disease, American College, Neuropilin, ATyr Pharma, Health, Inflammation, Organization, MD Anderson Cancer Center, Systemic scleroderma, College, Howard University Hospital, Abstract, Myelocyte, American Cancer Society, Pharmaceutical industry

Dr. Frederick is President Emeritus of Howard University, having served as President from 2014 to 2023.

Key Points: 
  • Dr. Frederick is President Emeritus of Howard University, having served as President from 2014 to 2023.
  • “We are honored to welcome a distinguished physician executive such as Dr. Frederick as an advisor to aTyr,” said Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer of aTyr.
  • He is also the distinguished Charles R. Drew Professor of Surgery at the Howard University College of Medicine and a practicing cancer surgeon at Howard University Hospital.
  • Dr. Frederick earned a B.S., M.D., and completed his surgical residency training at Howard University Hospital.

Surgical Instrument Tracking System Market to grow by USD 157.17 million from 2022 to 2027, North America to account for 41% of market growth- Technavio

Retrieved on: 
星期三, 九月 20, 2023
Paragon, Unique, Spine, Securitas, Medicare, Incidence, MHealth, EHR, SE, Conditional sentence, Securitas AB, Automation, ENT, Component, Telehealth, Clinical data management, American Surgical Association, BD (company), USD, Barcode, Hardware, Growth, Centers for Medicare & Medicaid Services, RFID, Biotechnology, FREE, Koch Industries, Ulcerative colitis, Fortive, Getinge Group, Research, Complex, Case Medical Centre, UDI, Skull, Large intestine, Instrument, Colorectal cancer, ROW, Unique Device Identification, Steris, CMMS, Medical device, Retail, Dentistry, Pharmaceutical industry, Software, Geography

NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The surgical instrument tracking system market is expected to grow by USD 157.17 million from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The surgical instrument tracking system market is expected to grow by USD 157.17 million from 2022 to 2027.
  • In addition, the momentum of the market will progress at a CAGR of 9.34% during the forecast period, according to Technavio Research.
  • Surgical Instrument Tracking System Market: Segmentation Analysis
    The market share growth by the hardware segment will be significant during the forecast period.
  • In addition, the mandatory adoption of Unique Device Identification (UDI) regulations in surgical instrument tracking is mainly expected to drive the growth of the hardware segment in the surgical instrument tracking system market.

Lustgarten Foundation Announces the Appointment of Two New Board Members

Retrieved on: 
星期四, 七月 13, 2023
Linda, Cloud, Pancreatic cancer, Society, Lustgarten Foundation for Pancreatic Cancer Research, Birmingham School of Law, University, American Surgical Association, Senior, Stanford University, PwC, Weak artificial intelligence, IBM/Google Cloud Computing University Initiative, Cancer, Dean, ...And You Will Know Us by the Trail of Dead, Research, Johns Hopkins School of Medicine, Doctor of Philosophy, UAB, Extrapyramidal system, National academy, Computation, National Academy of Medicine, Stanford University School of Medicine, Trustee, University of Minnesota Medical School, Memorial Sloan Kettering Cancer Center, MSK, FACS, Artificial intelligence, AI, Breast cancer, Pharmaceutical industry, Medical device, MD, Medicine

WOODBURY, N.Y., July 13, 2023 /PRNewswire-PRWeb/ -- The Lustgarten Foundation, the nation's largest private funder of pancreatic cancer research, today announced the appointment of two new board members: Selwyn M. Vickers, MD, FACS, and Scott Penberthy, PhD, MS. Dr. Vickers is an internationally recognized pancreatic cancer surgeon, pancreatic cancer researcher, and pioneer in health disparities research. Dr. Penberthy is a visionary engineering leader with extensive expertise in artificial intelligence (AI) and technology, specifically in the healthcare space.

Key Points: 
  • Selwyn M. Vickers, MD, FACS, and Scott Penberthy, PhD, MS, join the Lustgarten Foundation Board of Directors.
  • WOODBURY, N.Y., July 13, 2023 /PRNewswire-PRWeb/ -- The Lustgarten Foundation, the nation's largest private funder of pancreatic cancer research, today announced the appointment of two new board members: Selwyn M. Vickers, MD, FACS , and Scott Penberthy, PhD, MS .
  • "We are honored to welcome Dr. Vickers and Dr. Penberthy to the Lustgarten Foundation Board of Directors," said Linda Tantawi, CEO of the Lustgarten Foundation.
  • "At the Foundation, we firmly believe in the fundamental role of innovative and cutting-edge research in solving the complexities of pancreatic cancer.

Workday Elects Wayne A.I. Frederick, M.D. to Board of Directors

Retrieved on: 
星期三, 六月 22, 2022
New York state public-benefit corporations, Carnegie Corporation of New York, Democracy, WDAY, Howard University, Knowledge, Fellowship of the Royal Colleges of Surgeons, American College, American Surgical Association, Roswell Park Comprehensive Cancer Center, University, NASDAQ, Mutual, Humana, Forma, Mutual of America, Management

PLEASANTON, Calif., June 22, 2022 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources, today announced that its board of directors has elected Wayne A.I. Frederick, M.D. as an independent director.

Key Points: 
  • PLEASANTON, Calif., June 22, 2022 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources , today announced that its board of directors has elected Wayne A.I.
  • He is currently the president of his alma mater, Howard University, having held this position since July 2014.
  • Prior to this appointment, he was the institution's interim president after serving as its provost and chief academic officer.
  • He is a fellow of the American College of Surgeons and is a member of the American Surgical Association.

Pancreatic Cancer Lab-Grown Human Organoids May Predict Effective Chemotherapy Treatment

Retrieved on: 
星期四, 四月 7, 2022
Biotechnology, Pharmaceutical, Health, Oncology, Method, Cancer, Autoimmunity, LinkedIn, Feinstein Institute for Medical Research, Manuscript, Mental health, 3D, Dana–Farber Cancer Institute, Cold, Multimedia, Genetics, Cold Spring Harbor Laboratory, Lustgarten Foundation for Pancreatic Cancer Research, Research, Doctor of Philosophy, ASA, Medicine, Medical research, CEO, Neoplasm, Organoid, Molecular medicine, Annals of Surgery, Northwell Health, American Surgical Association, Institute, Cancer Institute, Cancer Research UK, Science, Credit, Pancreatic cancer, Patient, Medical imaging, Pharmaceutical industry, MD

It shows the ability to generate organoids from patients, regardless of tumor stage/progression or if the patient had already received chemotherapy.

Key Points: 
  • It shows the ability to generate organoids from patients, regardless of tumor stage/progression or if the patient had already received chemotherapy.
  • The findings suggest that lab testing of organoids may help predict chemotherapy effectiveness and enable patient-specific therapy plans.
  • While pancreatic cancer accounts for three percent of all cancers in the United States, it is responsible for seven percent of all cancer deaths.
  • The study collected 136 tumor samples from 117 patients with pancreatic cancer, including 32 percent of organoids derived from minority populations.

Yuman Fong, M.D., City of Hope’s Chair in Surgical Oncology, Elected to National Academy of Medicine

Retrieved on: 
星期一, 十月 18, 2021
Science, Biotechnology, Research, Surgery, Oncology, Health, Hospitals, Genetics, Instagram, Surgical Innovation, National Academies of Sciences, Engineering, and Medicine, Health equity, Bile, History, Diabetes, Technology, Center, National Cancer Institute, NAM, Surgical oncology, Solution, Liver, City of Hope National Medical Center, Translational Genomics Research Institute, Gallbladder, Biomedical Research, U.S. News & World Report, Cancer, National Academy of Medicine, City, News, National Comprehensive Cancer Network, American Surgical Association, YouTube, PLOS Biology, Multimedia, CAR, Health, Pancreas, National academy, Science, Caligiuri, Public health, Haematopoietic system, Virus, Immunotherapy, Twitter, City of Hope, Research, Biology, Robotics, NCI, Pharmaceutical industry

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    The National Academy of Medicine (NAM) honored Fong for transforming the fields of liver surgery, robotics in surgery, imaging and display in medicine, and gene therapy.
  • Fong has been a surgical oncologist at City of Hope since 2014 and serves as director of its Center for Surgical Innovation, director of its Center for International Medicine, and chair and professor of its Department of Surgery.
  • Founded in 1970, NAM is one of the three academies that make up the National Academies of Sciences, Engineering, and Medicine .
  • He is also City of Hopes Deana and Steve Campbell Physician-in-Chief Distinguished Chair.